IBDEI0AJ ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4404,1,3,0)
 ;;=3^Gout,Unspec
 ;;^UTILITY(U,$J,358.3,4404,1,4,0)
 ;;=4^M10.9
 ;;^UTILITY(U,$J,358.3,4404,2)
 ;;=^5010404
 ;;^UTILITY(U,$J,358.3,4405,0)
 ;;=Z79.4^^30^274^11
 ;;^UTILITY(U,$J,358.3,4405,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4405,1,3,0)
 ;;=3^Long Term (Current) Use of Insulin
 ;;^UTILITY(U,$J,358.3,4405,1,4,0)
 ;;=4^Z79.4
 ;;^UTILITY(U,$J,358.3,4405,2)
 ;;=^5063334
 ;;^UTILITY(U,$J,358.3,4406,0)
 ;;=Z79.83^^30^274^10
 ;;^UTILITY(U,$J,358.3,4406,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4406,1,3,0)
 ;;=3^Long Term (Current) Use of Bisphosphonates
 ;;^UTILITY(U,$J,358.3,4406,1,4,0)
 ;;=4^Z79.83
 ;;^UTILITY(U,$J,358.3,4406,2)
 ;;=^5063341
 ;;^UTILITY(U,$J,358.3,4407,0)
 ;;=I25.10^^30^275^1
 ;;^UTILITY(U,$J,358.3,4407,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4407,1,3,0)
 ;;=3^Athscl Hrt Disease w/o Angina Pectoris
 ;;^UTILITY(U,$J,358.3,4407,1,4,0)
 ;;=4^I25.10
 ;;^UTILITY(U,$J,358.3,4407,2)
 ;;=^5007107
 ;;^UTILITY(U,$J,358.3,4408,0)
 ;;=I25.9^^30^275^4
 ;;^UTILITY(U,$J,358.3,4408,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4408,1,3,0)
 ;;=3^Ischemic Hrt Disease,Chronic Unspec
 ;;^UTILITY(U,$J,358.3,4408,1,4,0)
 ;;=4^I25.9
 ;;^UTILITY(U,$J,358.3,4408,2)
 ;;=^5007144
 ;;^UTILITY(U,$J,358.3,4409,0)
 ;;=I50.9^^30^275^3
 ;;^UTILITY(U,$J,358.3,4409,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4409,1,3,0)
 ;;=3^Heart Failure,Unspec
 ;;^UTILITY(U,$J,358.3,4409,1,4,0)
 ;;=4^I50.9
 ;;^UTILITY(U,$J,358.3,4409,2)
 ;;=^5007251
 ;;^UTILITY(U,$J,358.3,4410,0)
 ;;=R03.0^^30^275^2
 ;;^UTILITY(U,$J,358.3,4410,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4410,1,3,0)
 ;;=3^Elevated B/P w/o Diagnosis of HTN
 ;;^UTILITY(U,$J,358.3,4410,1,4,0)
 ;;=4^R03.0
 ;;^UTILITY(U,$J,358.3,4410,2)
 ;;=^5019171
 ;;^UTILITY(U,$J,358.3,4411,0)
 ;;=J45.909^^30^276^2
 ;;^UTILITY(U,$J,358.3,4411,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4411,1,3,0)
 ;;=3^Asthma,Uncomplicated
 ;;^UTILITY(U,$J,358.3,4411,1,4,0)
 ;;=4^J45.909
 ;;^UTILITY(U,$J,358.3,4411,2)
 ;;=^5008256
 ;;^UTILITY(U,$J,358.3,4412,0)
 ;;=J44.9^^30^276^3
 ;;^UTILITY(U,$J,358.3,4412,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4412,1,3,0)
 ;;=3^COPD
 ;;^UTILITY(U,$J,358.3,4412,1,4,0)
 ;;=4^J44.9
 ;;^UTILITY(U,$J,358.3,4412,2)
 ;;=^5008241
 ;;^UTILITY(U,$J,358.3,4413,0)
 ;;=J18.9^^30^276^5
 ;;^UTILITY(U,$J,358.3,4413,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4413,1,3,0)
 ;;=3^Pneumonia,Unspec Organism
 ;;^UTILITY(U,$J,358.3,4413,1,4,0)
 ;;=4^J18.9
 ;;^UTILITY(U,$J,358.3,4413,2)
 ;;=^95632
 ;;^UTILITY(U,$J,358.3,4414,0)
 ;;=J30.9^^30^276^1
 ;;^UTILITY(U,$J,358.3,4414,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4414,1,3,0)
 ;;=3^Allergic Rhinitis,Unspec
 ;;^UTILITY(U,$J,358.3,4414,1,4,0)
 ;;=4^J30.9
 ;;^UTILITY(U,$J,358.3,4414,2)
 ;;=^5008205
 ;;^UTILITY(U,$J,358.3,4415,0)
 ;;=J15.9^^30^276^4
 ;;^UTILITY(U,$J,358.3,4415,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4415,1,3,0)
 ;;=3^Pneumonia,Bacterial
 ;;^UTILITY(U,$J,358.3,4415,1,4,0)
 ;;=4^J15.9
 ;;^UTILITY(U,$J,358.3,4415,2)
 ;;=^5008178
 ;;^UTILITY(U,$J,358.3,4416,0)
 ;;=C61.^^30^277^30
 ;;^UTILITY(U,$J,358.3,4416,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4416,1,3,0)
 ;;=3^Malig Neo of Prostate
 ;;^UTILITY(U,$J,358.3,4416,1,4,0)
 ;;=4^C61.
 ;;^UTILITY(U,$J,358.3,4416,2)
 ;;=^267239
 ;;^UTILITY(U,$J,358.3,4417,0)
 ;;=E55.9^^30^277^38
 ;;^UTILITY(U,$J,358.3,4417,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4417,1,3,0)
 ;;=3^Vitamin D Deficiency,Unspec
 ;;^UTILITY(U,$J,358.3,4417,1,4,0)
 ;;=4^E55.9
 ;;^UTILITY(U,$J,358.3,4417,2)
 ;;=^5002799
 ;;^UTILITY(U,$J,358.3,4418,0)
 ;;=D63.1^^30^277^8
